The European Alliance of Medical Research Infrastructures (EU-AMRI) is the result of the collaboration between three European research infrastructures, namely EATRIS-ERIC (focused on translational medicine), ECRIN-ERIC (focused on multinational clinical research) and BBMRI-ERIC (focused on biobanking and biomolecular resources). It aims to provide complementary services to researchers in the field of biomedical sciences and support the development of personalised medicine and new treatments. Established in 2020, EU-AMRI comprises over 700 research institutions and university hospitals, 29 European Countries as Members or Observers, working to improve the research process and tackle unmet medical needs. EU-AMRI continues to play a meaningful role in the global response to COVID-19, dealing with challenges related to diagnostic tests, biomarker development, development of treatments and vaccines for COVID-19.
EU-AMRI Launch Event – 14 December 2021, Brussels:
On the morning of 14 December 2021 (10:00 – 12:00 CET), EU-AMRI will be formally launched in Brussels. The programme will include a presentation of EU-AMRI and will be followed by a round-table discussion with important stakeholders for the future of the EU-AMRI Alliance.
For more information, visit the EU AMRI website.